Physician

Oncology

Dr. Pierre Saintigny, MD

Pierre Saintigny practices Oncology. Pierre Saintigny has written publications. He has 38 publications published with PubMed. The lastest publication is: 'The myosin filament XV assembly: contributions of 195 residue segments of the myosin rod and the eight C-terminal residues.'

Publications

New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development.
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.
Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!
Proliferative verrucous leukoplakia (PVL): Recognition and differentiation from conventional leukoplakia and mimics!
Detailed Genome-Wide SNP Analysis of Major Salivary Carcinomas Localizes Subtype-Specific Chromosome Sites and Oncogenes of Potential Clinical Significance.
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhi...
Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung Cancer patients after definitive surgery by expression prof...
CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in Lung adenocarcinoma.
Global evaluation of Eph receptors and ephrins in Lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.
Recent advances in non-small cell lung Cancer biology and clinical management.
Genes suppressed by DNA methylation in non-small cell lung Cancer reveal the epigenetics of epithelial-mesenchymal transition.
[A controlled study of postoperative radiotherapy for patients with completely resected non small cell Lung carcinoma].
The myosin filament XV assembly: contributions of 195 residue segments of the myosin rod and the eight C-terminal residues.
[Micro-metastases and non-small cell lung Cancer].
[Gefitinib treatment for carcinomatous meningitis in non-small cell lung Cancer].
Detection of occult carcinomatous diffusion in lymph nodes from head and neck squamous cell carcinoma using real-time RT-PCR detection of cytokeratin 19 mRNA.
Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung Cancer cells.
Antitumour efficacy of MEK inhibitors in human lung Cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors.
Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast Cancer patients.
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome.
Effect of low-fat diets on plasma levels of NF-?B-regulated inflammatory cytokines and angiogenic factors in men with prostate Cancer.
Epidermal growth factor receptor expression and gene copy number in the risk of oral Cancer.
Gene expression profiling predicts the development of oral Cancer.
Bronchioloalveolar carcinoma: a translational perspective.
miR-200 Inhibits Lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
Heterotransplant mouse model cohorts of human malignancies: A novel platform for Systematic Preclinical Efficacy Evaluation of Drugs (SPEED).
DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral Cancer in patients with leukoplakia.
Erythropoietin-producing lung Cancer.
Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung Cancer.
Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung Cancer: concurrent expression in Cancer cells from primary tumour and metastatic l...
Late cerebellar relapse of a juvenile bronchial carcinoid.
Tumor lysis associated with sudden onset of syndrome of inappropriate antidiuretic hormone secretion.
[Cardiovascular toxicity of some Cancer agents (others than anthracyclines, fluoropyrimidines and trastuzumab)].
[Dose density and dose intensity in the treatment of breast Cancer].
Real-time RT-PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell Lung carcinoma.
[Non-metastatic intrahepatic cholestasis associated with bronchial adenocarcinoma].
Case study: effectiveness of plasma exchange in an adolescent with Systemic lupus erythematosus and catatonia.

Procedures Preformed

Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
Thoracentesis

Conditions Treated

Adrenal Gland Cancer
Anemia
Bladder Cancer
Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
View All

Doctors Specialties

Medical Oncology
Oncology

Accepted Insurances

Cigna
GEHA
Humana
Medical Mutual of Ohio
Medicare MCR
Molina
Thrivent Financial
United Healthcare

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Shagufta N. Naqvi, MD This Doctor is OpenDoctor Recommended.
	Dr. Nikesh Jasani, MD This Doctor is OpenDoctor Recommended.
	Dr. William N. William Jr., MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Anne Tsao, MD This Doctor is OpenDoctor Recommended.
	Dr. Eric Jonasch, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Kristy L. Richards, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Abenaa M. Brewster, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Waun K. Hong, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Chad Pecot, MD This Doctor is OpenDoctor Recommended.
	Dr. Werner A. Bleyer, MD This Doctor is OpenDoctor Recommended.
	Dr. Dongxin Liu, MD This Doctor is OpenDoctor Recommended.
	Dr. Gabriel Lopez-Berestein, MD This Doctor is OpenDoctor Recommended.
	Dr. Vivian T. Yin, MD This Doctor is OpenDoctor Recommended.